Outsmart HPV:基于网络的HPV疫苗接种干预在年轻男同性恋和双性恋男性中的可接受性与短期效果
2016年在美国招募150名18-25岁未接种HPV疫苗的年轻男同性恋和双性恋男性,随机分为标准信息对照组和Outsmart HPV干预组。干预组在男性性行为者肛癌风险感知(b=0.34)、HPV疫苗接种自我效能(b=0.15)和感知疫苗危害减少(b=-0.34)上优于对照组(均p<.05)。干预可接受性和满意度高(5点量表均>4.4),但疫苗 uptake 效果待确定。
要点
- 与对照组相比,干预组认为男男性行为者肛癌风险更高的感知更强(b=0.34)。
- 干预组HPV疫苗接种自我效能更高(b=0.15),感知疫苗危害更少(b=-0.34),均p<.05。
- 干预可接受性和满意度高(5点量表均>4.4),但对疫苗 uptake 的影响待确定。
核心结论
- 研究为简短的、量身定制的网络干预改善年轻男同性恋和双性恋男性HPV疫苗接种态度和信念提供了初步支持。
- 重要的下一步是确定Outsmart HPV对HPV疫苗 uptake 的影响。
研究设计与样本
- 2016年在美国招募150名18-25岁未接种任何HPV疫苗剂次的年轻男同性恋和双性恋男性。
- 参与者随机接受标准HPV疫苗接种信息(对照组)或人群靶向、个体化定制内容(Outsmart HPV干预组)。
- 使用多元线性回归评估干预后立即的组间HPV疫苗接种态度和信念差异。
主要发现
- 基线时两组在HPV疫苗接种态度、信念和意图上无差异。
- 与对照组相比,干预组报告认为男男性行为者相对其他男性肛癌风险更高的感知更强(b=0.34)。
- 与对照组相比,干预组报告HPV疫苗接种自我效能更高(b=0.15)。
- 与对照组相比,干预组报告感知HPV疫苗危害更少(b=-0.34)。
- 干预组对Outsmart HPV干预的可接受性和满意度高(5点量表均>4.4)。
关键数值与推荐
- 组间比较均p<.05。
- 可接受性和满意度5点量表均>4.4。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Effective interventions to promote human papillomavirus (HPV) vaccination are needed, particularly among populations at increased risk of HPV-related disease. We developed and pilot tested a web-based intervention, Outsmart HPV, to promote HPV vaccination among young gay and bisexual men (YGBM). METHODS: In 2016, we recruited a national sample (n = 150) of YGBM ages 18-25 in the United States who had not received any doses of HPV vaccine. Participants were randomized to receive either standard HPV vaccination information (control) or population-targeted, individually-tailored content (Outsmart HPV intervention). We assessed between group differences in HPV vaccination attitudes and beliefs immediately following the intervention using multiple linear regression. RESULTS: There were no differences in HPV vaccination attitudes, beliefs and intentions between groups at baseline. Compared to participants in the control group, intervention participants reported: greater perception that men who have sex with men are at higher risk for anal cancer relative to other men (b = 0.34); greater HPV vaccination self-efficacy (b = 0.15); and fewer perceived harms of HPV vaccine (b = -0.34) on posttest surveys (all p < .05). Overall, intervention participants reported high levels of acceptability and satisfaction with the Outsmart HPV intervention (all > 4.4 on a 5-point scale). CONCLUSIONS: Findings from this study provide preliminary support for a brief, tailored web-based intervention in improving HPV vaccination attitudes and beliefs among YGBM. An important next step is to determine the effects of Outsmart HPV on HPV vaccine uptake. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov identifier NCT02835755.
引用
- McRee AL, Shoben A, Bauermeister JA, et al. Outsmart HPV: Acceptability and short-term effects of a web-based HPV vaccination intervention for young adult gay and bisexual men. Vaccine. 2018. PMID: 29331245. doi:10.1016/j.vaccine.2018.01.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。